EO Denis, MD Shawn Aaron, MD Jean Bourbeau … - Can Respir J, 2007 - progettolibra.it *Member of the editorial committee 1Queen's University, Kingston; 2University of
Ottawa, Ottawa, Ontario; 3McGill University, Montreal, Quebec; 4Dalhousie
University, Halifax, Nova Scotia; 5University of Saskatchewan, Saskatoon, ... Cited by 68 - Related articles - All 18 versions
TJ Wilt, D Niewoehner, R MacDonald, RL … - Annals of Internal Medicine, 2007 - Am Coll Physicians Background: Chronic obstructive pulmonary disease (COPD) is a common and
disabling condition in adults. Information about therapeutic effectiveness and
adverse effects of common treatment options and how clinical and ... Cited by 57 - Related articles - BL Direct - All 12 versions
JA Wedzicha, TAR Seemungal - The Lancet, 2007 - Elsevier Exacerbations of chronic obstructive pulmonary disease (COPD) are episodes of
worsening of symptoms, leading to substantial morbidity and mortality. COPD
exacerbations are associated with increased airway and systemic ... Cited by 48 - Related articles - All 9 versions
A Qaseem, V Snow, P Shekelle, K Sherif, TJ … - Annals of Internal Medicine, 2007 - Am Coll Physicians Recommendation 1: In patients with respiratory symptoms, particularly dyspnea,
spirometry should be performed to diagnose airflow obstruction. Spirometry
should not be used to screen for airflow obstruction in asymptomatic ... Cited by 43 - Related articles - BL Direct - All 18 versions
KF Rabe, B Beghe, F Luppi, LM Fabbri - American journal of respiratory and critical care …, 2007 - ajrccm.org.p.angrylapdog.com The positive aspects in the definition of COPD—initially introduced by the
American Thoracic Society/European Respiratory Society statement (2) in
2004—have been adopted in recent updated guidelines defining the disease ... Cited by 26 - Related articles - BL Direct - All 9 versions
- ►utmem.edu [PDF] MB Drummond, EC Dasenbrook, MW Pitz, DJ … - JAMA, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 24 - Related articles - All 8 versions
- ►ersjournals.com S Suissa, P Ernst, KL Vandemheen, SD Aaron - European Respiratory Journal, 2008 - Eur Respiratory Soc First, among previous ICS users in the Canadian Optimal Therapy of COPD Trial,
the hazard ratio of the first exacerbation with ICS relative to bronchodilators
was 0.71 (95% confidence interval (CI) 0.53–0.96), while among those not ... Cited by 25 - Related articles - BL Direct - All 8 versions
- ►critcaremed.com SD Aaron, D Fergusson, GB Marks, S Suissa, … - British Medical Journal, 2008 - thorax.bmj.com Results: 22 trials (17 156 patients) met the inclusion criteria and were
reviewed. None of the trials adjudicated exacerbations or determined
independence of events. 14/22 studies (64%) introduced selection bias by ... Cited by 24 - Related articles - BL Direct - All 6 versions
- ►casemedicine.com [PDF] PMA Calverley, SI Rennard - The Lancet, 2007 - Elsevier Although the development of effective treatments for patients with chronic
obstructive pulmonary disease (COPD) has not been seen as a high priority, the
past decade has seen a substantial increase in the number of clinical ... Cited by 18 - Related articles - All 9 versions
BR Celli - Chest, 2008 - chestjournal.chestpubs.org COPD is highly prevalent and will continue to be an increasing cause of
morbidity and mortality worldwide. COPD is now viewed under a new paradigm as
preventable and treatable. In addition, it has become accepted that COPD is ... Cited by 19 - Related articles - All 7 versions
